Avstera Therapeutics: Funding, Investors & Team (Aug 2026)
A specialty oncology-focused biopharmaceutical company with a large pipeline of novel small molecules and biologics that focuses on the science underpinning tumor biology while methodologically breaking down barriers and employing cutting-edge techniques to provide cancer patients with effective treatments.
Avstera Therapeutics has raised $9.6M across 2 funding rounds on record, the most recent an undisclosed round of $5.0M announced in Oct 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Avstera Therapeutics Company Profile and Key Stats
Latest funding round on record: Oct 2023.
Avstera Therapeutics Funding Rounds
Avstera Therapeutics raised $4.6M in a Seed announced in Nov 2022.
11 months later, an undisclosed round of $5.0M was announced in Oct 2023.
Avstera Therapeutics Founders and Leadership Team
Contact details for the Avstera Therapeutics team: 1 of 2 have an email address on file.
Start 14-day free trial →Avstera Therapeutics Funding Compared to Other Biotechnology Startups
Avstera Therapeutics' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Avstera Therapeutics in Biotechnology and Philadelphia
Companies Similar to Avstera Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Avstera Therapeutics Funding FAQs
What does Avstera Therapeutics do?
A specialty oncology-focused biopharmaceutical company with a large pipeline of novel small molecules and biologics that focuses on the science underpinning tumor biology while methodologically breaking down barriers and employing cutting-edge techniques to provide cancer patients with effective treatments.
How much funding has Avstera Therapeutics raised?
Avstera Therapeutics has raised $9.6M across 2 rounds on record. The most recent is an undisclosed round of $5.0M announced in Oct 2023.
When did Avstera Therapeutics last raise funding?
Avstera Therapeutics' most recent funding round on record is an undisclosed round of $5.0M, announced in Oct 2023.
Who founded Avstera Therapeutics?
FundedIQ lists Ajay Raju (Founder) at Avstera Therapeutics.
Who is the CEO of Avstera Therapeutics?
Karthik Musunuri is listed as CEO at Avstera Therapeutics.
Where is Avstera Therapeutics headquartered?
Avstera Therapeutics is based in Philadelphia, Pennsylvania, United States.
How many employees does Avstera Therapeutics have?
Avstera Therapeutics is in the 1-10 employee band.
How does Avstera Therapeutics' funding compare to other Biotechnology startups?
Avstera Therapeutics' latest round of $5.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Avstera Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Avstera Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.